Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why BioNTech Thrashed the Market on Thursday


Top coronavirus stock BioNTech (NASDAQ: BNTX) was also tops with investors on Thursday. The Germany-based biotech's shares trounced the S&P 500 by closing the day more than 4% higher, thanks to some positive -- if expected -- news on the regulatory front.

Comirnaty, the coronavirus vaccine developed by BioNTech in partnership with U.S. pharmaceutical sector giant Pfizer (NYSE: PFE), was granted Emergency Use Authorization as a booster by the Food and Drug Administration Wednesday night.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments